Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial.

被引：1
|
作者：
Ribi, K.
Aldridge, J.
Phillips, K.
Sun, Z.
Thompson, A. M.
Harvey, V. J.
Thuerlimann, B.
Cardoso, F.
Coates, A. S.
Bernhard, J.
机构：
[1] Int Beast Canc Study Grp, Bern, Switzerland
[2] Dana Farber Canc Inst, Int Beast Canc Study Grp Stat Ctr, Boston, MA 02115 USA
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Univ Dundee, Dundee, Scotland
[5] Auckland Hosp, Auckland, New Zealand
[6] Kantonsspital St Gallen, Breast Ctr, St Gallen, Switzerland
[7] Inst Jules Bordet, B-1000 Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
527
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial
    Ribi, K. E.
    Phillips, K. A.
    Sun, Z.
    Stephens, A.
    Thompson, A.
    Harvey, V.
    Thuerlimann, B.
    Cardoso, F.
    Coates, A. S.
    Bernhard, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Phillips, Kelly-Anne
    Aldridge, Julie
    Ribi, Karin
    Sun, Zhuoxin
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 221 - 226
  • [3] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Kelly-Anne Phillips
    Julie Aldridge
    Karin Ribi
    Zhuoxin Sun
    Alastair Thompson
    Vernon Harvey
    Beat Thürlimann
    Fatima Cardoso
    Olivia Pagani
    Alan S. Coates
    Aron Goldhirsch
    Karen N. Price
    Richard D. Gelber
    Jürg Bernhard
    Breast Cancer Research and Treatment, 2011, 126 : 221 - 226
  • [4] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
    Phillips, Kelly-Anne
    Ribi, Karin
    Sun, Zhuoxin
    Stephens, Alisa
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST, 2010, 19 (05): : 388 - 395
  • [5] Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
    Ewertz, Marianne
    Gray, Kathryn P.
    Regan, Meredith M.
    Ejlertsen, Bent
    Price, Karen N.
    Thuerlimann, Beat
    Bonnefoi, Herve
    Forbes, John F.
    Paridaens, Robert J.
    Rabaglio, Manuela
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Smith, Ian E.
    Coates, Alan S.
    Goldhirsch, Aron
    Mouridsen, Henning T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3967 - 3975
  • [6] Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
    Munzone, E.
    Giobbie-Hurder, A.
    Gusterson, B. A.
    Mallon, E.
    Viale, G.
    Thurlimann, B.
    Ejlertsen, B.
    MacGrogan, G.
    Bibeau, F.
    Lelkaitis, G.
    Price, K. N.
    Gelber, R. D.
    Coates, A. S.
    Goldhirsch, A.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2015, 26 (12) : 2442 - 2449
  • [7] Subjective cognitive complaints one year after ceasing adjuvant endocrine therapy for early-stage breast cancer: Findings from the Breast International Group (BIG) 1-98 trial.
    Phillips, Kelly-Anne
    Ribi, Karin
    Aldridge, Julie
    Thompson, Alastair Mark
    Harvey, Vernon J.
    Thurlimann, Beat J. K.
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan Stuart
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
    DeCensi, Andrea
    Sun, Zhuoxin
    Guerrieri-Gonzaga, Aliana
    Thuerlimann, Beat
    McIntosh, Christina
    Tondini, Carlo
    Monnier, Alain
    Campone, Mario
    Debled, Marc
    Schoenenberger, Astrid
    Zaman, Khalil
    Johansson, Harriet
    Price, Karen N.
    Gelber, Richard D.
    Goldhirsch, Aron
    Coates, Alan S.
    Aebi, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 321 - 329
  • [9] Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    Regan, Meredith M.
    Price, Karen N.
    Giobbie-Hurder, Anita
    Thuerlimann, Beat
    Gelber, Richard D.
    BREAST CANCER RESEARCH, 2011, 13 (03)
  • [10] Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    Meredith M Regan
    Karen N Price
    Anita Giobbie-Hurder
    Beat Thürlimann
    Richard D Gelber
    Breast Cancer Research, 13
12345